114 related articles for article (PubMed ID: 26337105)
1. Advances in the Development of Multimodal Imaging Agents for Nuclear/Near-infrared Fluorescence Imaging.
Ghosh SC; Azhdarinia A
Curr Med Chem; 2015; 22(29):3390-404. PubMed ID: 26337105
[TBL] [Abstract][Full Text] [Related]
2. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
[TBL] [Abstract][Full Text] [Related]
3. Dual-labeling strategies for nuclear and fluorescence molecular imaging: a review and analysis.
Azhdarinia A; Ghosh P; Ghosh S; Wilganowski N; Sevick-Muraca EM
Mol Imaging Biol; 2012 Jun; 14(3):261-76. PubMed ID: 22160875
[TBL] [Abstract][Full Text] [Related]
4. Multimodal chelation platform for near-infrared fluorescence/nuclear imaging.
Ghosh SC; Ghosh P; Wilganowski N; Robinson H; Hall MA; Dickinson G; Pinkston KL; Harvey BR; Sevick-Muraca EM; Azhdarinia A
J Med Chem; 2013 Jan; 56(2):406-16. PubMed ID: 23214723
[TBL] [Abstract][Full Text] [Related]
5. A novel Tc-99 m and fluorescence labeled peptide as a multimodal imaging agent for targeting angiogenesis in a murine tumor model.
Kim MH; Kim CG; Kim SG; Kim DW
Contrast Media Mol Imaging; 2016 Nov; 11(6):527-534. PubMed ID: 27739174
[TBL] [Abstract][Full Text] [Related]
6. Multimodal nanoparticle imaging agents: design and applications.
Burke BP; Cawthorne C; Archibald SJ
Philos Trans A Math Phys Eng Sci; 2017 Nov; 375(2107):. PubMed ID: 29038384
[TBL] [Abstract][Full Text] [Related]
7. Rapid aqueous [18F]-labeling of a bodipy dye for positron emission tomography/fluorescence dual modality imaging.
Li Z; Lin TP; Liu S; Huang CW; Hudnall TW; Gabbaï FP; Conti PS
Chem Commun (Camb); 2011 Sep; 47(33):9324-6. PubMed ID: 21779546
[TBL] [Abstract][Full Text] [Related]
8. Quantifying multimodal contrast agent biological activity using near-infrared flow cytometry.
Hall MA; Aldrich MB; Azhdarinia A; Lachance PA; Robinson H; Hazen A; Haviland DL; Sevick-Muraca EM
Contrast Media Mol Imaging; 2012; 7(3):338-45. PubMed ID: 22539404
[TBL] [Abstract][Full Text] [Related]
9. Modular Assembly of Multimodal Imaging Agents through an Inverse Electron Demand Diels-Alder Reaction.
Canovas C; Moreau M; Vrigneaud JM; Bellaye PS; Collin B; Denat F; Goncalves V
Bioconjug Chem; 2019 Mar; 30(3):888-897. PubMed ID: 30742423
[TBL] [Abstract][Full Text] [Related]
10. Bioorthogonal Fluorophore Linked DFO-Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies.
Meimetis LG; Boros E; Carlson JC; Ran C; Caravan P; Weissleder R
Bioconjug Chem; 2016 Jan; 27(1):257-63. PubMed ID: 26684717
[TBL] [Abstract][Full Text] [Related]
11. Cartilage-Specific Near-Infrared Fluorophores for Biomedical Imaging.
Hyun H; Owens EA; Wada H; Levitz A; Park G; Park MH; Frangioni JV; Henary M; Choi HS
Angew Chem Int Ed Engl; 2015 Jul; 54(30):8648-52. PubMed ID: 26095685
[TBL] [Abstract][Full Text] [Related]
12. Targeted radionuclide and fluorescence dual-modality imaging of cancer: preclinical advances and clinical translation.
Lütje S; Rijpkema M; Helfrich W; Oyen WJ; Boerman OC
Mol Imaging Biol; 2014 Dec; 16(6):747-55. PubMed ID: 24849133
[TBL] [Abstract][Full Text] [Related]
13. A high-performance imaging probe with NIR luminescence and synergistically enhanced T1-T2 relaxivity for in vivo hepatic tumor targeting and multimodal imaging.
Liu J; Li Z; Yang X; Liu W; Wang B; Zhu Y; Mu K; Zhu W
Chem Commun (Camb); 2015 Sep; 51(69):13369-72. PubMed ID: 26207340
[TBL] [Abstract][Full Text] [Related]
14. Near-infrared fluorescence optical imaging and tomography.
Gurfinkel M; Ke S; Wen X; Li C; Sevick-Muraca EM
Dis Markers; 2003-2004; 19(2-3):107-21. PubMed ID: 15096708
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence labeled microbubbles for multimodal imaging.
Barrefelt Å; Zhao Y; Larsson MK; Egri G; Kuiper RV; Hamm J; Saghafian M; Caidahl K; Brismar TB; Aspelin P; Heuchel R; Muhammed M; Dähne L; Hassan M
Biochem Biophys Res Commun; 2015 Aug; 464(3):737-42. PubMed ID: 26187672
[TBL] [Abstract][Full Text] [Related]
16. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
[TBL] [Abstract][Full Text] [Related]
17. Design of peptide imaging agents for whole-body and intraoperative molecular imaging.
Moss JA; Vāvere AL; Azhdarinia A
Curr Med Chem; 2012; 19(20):3255-65. PubMed ID: 22664243
[TBL] [Abstract][Full Text] [Related]
18. Dual-Modality Noninvasive Mapping of Sentinel Lymph Node by Photoacoustic and Near-Infrared Fluorescent Imaging Using Dye-Loaded Mesoporous Silica Nanoparticles.
Liu Z; Rong P; Yu L; Zhang X; Yang C; Guo F; Zhao Y; Zhou K; Wang W; Zeng W
Mol Pharm; 2015 Sep; 12(9):3119-28. PubMed ID: 26132789
[TBL] [Abstract][Full Text] [Related]
19. New Developments in Dual-Labeled Molecular Imaging Agents.
Hernandez Vargas S; Ghosh SC; Azhdarinia A
J Nucl Med; 2019 Apr; 60(4):459-465. PubMed ID: 30733318
[TBL] [Abstract][Full Text] [Related]
20. Preventing Radiobleaching of Cyanine Fluorophores Enhances Stability of Nuclear/NIRF Multimodality Imaging Agents.
Hernandez R; Heskamp S; Rijpkema M; Bos DL; Goldenberg DM; McBride WJ; Morgenstern A; Bruchertseifer F; Cai W; Boerman OC
Theranostics; 2017; 7(1):1-8. PubMed ID: 28042311
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
